Neutrophil-lymphocyte ratio as prognostic factor in metastatic breast cancer
Revista Brasileira de Ginecologia e Obstetrícia · 13.05.2026 · 48
DOI: 10.61622/rbgo/2026rbgo10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Brasileira de Ginecologia e Obstetrícia, erschienen am 13.05.2026. Verfasst von Gustavo Motta Cabello Dos Santos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto Departamento de Ginecologia e Obstetrícia Ribeirão PretoSP Brazil Departamento de G…. Hauptthemen laut MEDLINE: Breast Neoplasms, Neutrophils, Lymphocytes. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
The aim of the study was to analyze the role of the neutrophil to lymphocyte ratio (NLR) as a prognostic factor in metastatic breast cancer (MBC).
Methods
A retrospective cohort study including 359 recurrent MBC patients was performed. Clinical and pathological attributes were retrieved from patients’ medical files and their importance in the overall survival were evaluated using the Cox univariate and multivariate proportional hazard models. A confidence interval of 95% was used to select significant variables and the Wald test was used to infer the best NLR cutoff value to discriminate into low and high categories.
Results
In univariate analyses, the variables estrogen receptor (ER) and progesterone receptor (PR) expressions, previous treatment with adjuvant chemo, NLR, PLR (platelet-lymphocyte ratio), age at diagnosis and the main metastatic site (bone/lymph node, visceral or central nervous system) variables were significant to determine the hazards. After filtering the collinear variables, the final model was tested with 6 variables based on 339 patients and the NLR at the time of the recurrence diagnosis (NLR_rec), the hormone receptor (ER or PR) status and the age at diagnosis were considered significant. The best NLR_rec value to discriminate against patients was 4.43 (Wald test= 51.7) and there were 239 patients categorized as low and 111 as high NLR category. The median overall survival time was 18 and 4 months in NLR-low and NLR-high groups, respectively (p< 0.001).
Conclusion
NLR is an independent prognostic factor in recurrent MBC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto Departamento de Ginecologia e Obstetrícia Ribeirão PretoSP Brazil Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Uni…
ORCID-Profile: Gustavo Motta Cabello Dos Santos, Nereida Kilza Costa-Lima, Isabela da Mata Tiezzi, Giovana Kobayashi Pavão, Israel Geraldo Silva, Priscila Malara Maia, Hélio Humberto Angotti Carrara, Daniel Guimarães Tiezzi
Zitieren
APA
Dos Santos, G. M. C., Costa-Lima, N. K., Tiezzi, I. D. M., Pavão, G. K., Silva, I. G., Maia, P. M., Carrara, H. H. A., & Tiezzi, D. G. (2026). Neutrophil-lymphocyte ratio as prognostic factor in metastatic breast cancer. Revista Brasileira de Ginecologia e Obstetrícia, 48. https://doi.org/10.61622/rbgo/2026rbgo10
Vancouver
Dos Santos GMC, Costa-Lima NK, Tiezzi IDM, Pavão GK, Silva IG, Maia PM, et al. Neutrophil-lymphocyte ratio as prognostic factor in metastatic breast cancer. Revista Brasileira de Ginecologia e Obstetrícia. 2026;48. doi:10.61622/rbgo/2026rbgo10
BibTeX
@article{DosSantos2026,
author = {Dos Santos, Gustavo Motta Cabello and Costa-Lima, Nereida Kilza and Tiezzi, Isabela da Mata and Pavão, Giovana Kobayashi and Silva, Israel Geraldo and Maia, Priscila Malara and Carrara, Hélio Humberto Angotti and Tiezzi, Daniel Guimarães},
title = {Neutrophil-lymphocyte ratio as prognostic factor in metastatic breast cancer},
journal = {Revista Brasileira de Ginecologia e Obstetrícia},
year = {2026},
volume = {48},
doi = {10.61622/rbgo/2026rbgo10}
}
EUVIMED